Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cameron, N. E.
Right arrow Articles by Robertson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cameron, N. E.
Right arrow Articles by Robertson, S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 40, Issue 5 532-539, Copyright © 1991 by American Diabetes Association


ARTICLES

Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats

NE Cameron, MA Cotter and S Robertson
Division of Physiology, School of Biomedical Sciences, University of Aberdeen, Scotland, United Kingdom.

Effects of essential fatty acids on nerve conduction, hypoxic resistance, skeletal muscle contractile properties, and capillary density were examined in streptozocin-induced diabetic rats. Nondiabetic and diabetic controls and three diabetic groups treated with 10% supplements of corn oil, evening primrose oil (Efamol), or a mixture of 80% evening primrose oil and 20% fish oil (Efamol Marine) for 2 mo were used. Efamol and Efamol Marine increased plasma gamma-linolenic acid levels, but arachidonic acid was elevated only with Efamol. Diabetes resulted in 15-29% reductions in sciatic motor and sensory saphenous nerve conduction velocity. Efamol prevented conduction deficits more effectively than Efamol Marine, and corn oil had no effect. In vitro measurement of sciatic nerve hypoxic resistance revealed a 49% increase in the time taken for action potential amplitude to decline by 50% with diabetes. Corn oil had no significant effect. With Efamol, hypoxic resistance was within the nondiabetic range. Efamol Marine produced intermediate results. Functional improvements may relate to enhanced vasa nervorum perfusion, because endoneurial capillary density increased by 22% with Efamol, angiogenesis perhaps resulting from eicosanoid production from arachidonic acid. Soleus muscle contractions were prolonged by diabetes. This was partially corrected by treatment, Efamol being most effective. Extensor digitorum longus muscle had reduced tetanic tension with diabetes, and this was prevented by all treatments. Soleus showed a modest increase in capillarization with Efamol, which may have contributed to reduced susceptibility to fatigue. The data suggest involvement of abnormal fatty acid metabolism in the etiology of diabetic neuropathy and myopathy.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. C. Frisbee
Impaired skeletal muscle perfusion in obese Zucker rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1124 - R1134.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Tang, H. P. Cho, M. T. Nakamura, and S. D. Clarke
Regulation of human {Delta}-6 desaturase gene transcription: identification of a functional direct repeat-1 element
J. Lipid Res., April 1, 2003; 44(4): 686 - 695.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
K. M. Halat and C. E. Dennehy
Botanicals and Dietary Supplements in Diabetic Peripheral Neuropathy
J Am Board Fam Med, January 1, 2003; 16(1): 47 - 57.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. C.J. Yuen, N. R. Baker, and G. Rayman
Treatment of Chronic Painful Diabetic Neuropathy With Isosorbide Dinitrate Spray: A double-blind placebo-controlled cross-over study
Diabetes Care, October 1, 2002; 25(10): 1699 - 1703.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Pop-Busui, V. Marinescu, C. Van Huysen, F. Li, K. Sullivan, D. A. Greene, D. Larkin, and M. J. Stevens
Dissection of Metabolic, Vascular, and Nerve Conduction Interrelationships in Experimental Diabetic Neuropathy by Cyclooxygenase Inhibition and Acetyl-L-Carnitine Administration
Diabetes, August 1, 2002; 51(8): 2619 - 2628.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Nakamura, N. Koh, F. Sakakibara, Y. Hamada, T. Hara, H. Sasaki, S. Chaya, T. Komori, E. Nakashima, K. Naruse, et al.
Polyol Pathway Hyperactivity Is Closely Related to Carnitine Deficiency in the Pathogenesis of Diabetic Neuropathy of Streptozotocin-Diabetic Rats
J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 897 - 902.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1991 by the American Diabetes Association.